Acute Myeloid Leukemia
Showing NaN - NaN of 62
Myeloid Malignancy, Acute Myeloid Leukemia Trial in Cleveland (Venetoclax, Decitabine)
Not yet recruiting
- Myeloid Malignancy
- Acute Myeloid Leukemia
-
Cleveland, OhioUniversity Hospitals Seidman Cancer, Case Comprehensive Cancer C
Nov 8, 2023
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Mixed-Phenotype Leukemia Trial in United States (BMF-500)
Not yet recruiting
- Acute Myeloid Leukemia
- +2 more
-
Los Angeles, California
- +9 more
Jun 27, 2023
Acute Myeloid Leukemia, Down Syndrome, Myelodysplastic Syndrome Trial in Worldwide (Asparaginase, Asparaginase Erwinia
Active, not recruiting
- Acute Myeloid Leukemia
- +4 more
- Asparaginase
- +7 more
-
Birmingham, Alabama
- +190 more
Jan 30, 2023
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts-2 Trial in United States (drug,
Active, not recruiting
- Acute Myeloid Leukemia
- +2 more
- Azacitidine
- +5 more
-
Anchorage, Alaska
- +506 more
Jan 28, 2023
Colorectal Cancer, Hematologic Malignancy, Rectum Cancer Trial in Cleveland (Vactosertib, Fludarabine Phosphate,
Recruiting
- Colorectal Cancer
- +11 more
- Vactosertib
- +4 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 18, 2023
Acute Myeloid Leukemia Trial in Worldwide (Magrolimab, Venetoclax, Azacitidine)
Recruiting
- Acute Myeloid Leukemia
- Magrolimab
- +3 more
-
Little Rock, Arkansas
- +82 more
Jan 17, 2023
Acute Myeloid Leukemia Trial in Canada, United States (Clinical Observation, Laboratory Biomarker Analysis, Nivolumab)
Active, not recruiting
- Acute Myeloid Leukemia
- Clinical Observation
- +2 more
-
Birmingham, Alabama
- +45 more
Dec 30, 2022
Acute Myeloid Leukemia Trial in United States (Gilteritinib, Midostaurin, Daunorubicin)
Active, not recruiting
- Acute Myeloid Leukemia
- Gilteritinib
- +3 more
-
Scottsdale, Arizona
- +43 more
Nov 17, 2022
Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia, Acute Megakaryoblastic Leukemia Trial in United States (drug, radiation,
Recruiting
- Acute Erythroid Leukemia
- +10 more
- Fludarabine
- +5 more
-
San Francisco, California
- +5 more
Nov 1, 2022
Acute Myeloid Leukemia, Stem Cell Transplantation Trial in United States (MT-401)
Recruiting
- Acute Myeloid Leukemia
- Stem Cell Transplantation
-
Birmingham, Alabama
- +15 more
Aug 22, 2022
Acute Myeloid Leukemia Trial in United States (Cyclophosphamide, Fludarabine, KITE-222)
Recruiting
- Acute Myeloid Leukemia
- Cyclophosphamide
- +2 more
-
Stanford, California
- +6 more
Aug 10, 2022
Collecting and Storing Tissue From Young Patients With Cancer
Recruiting
- Acute Lymphoblastic Leukemia
- +13 more
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Birmingham, Alabama
- +68 more
Aug 4, 2022
Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell
Recruiting
- Acute Myeloid Leukemia
- +2 more
-
Brisbane, California
- +4 more
Jul 18, 2022
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in France, United States (SY-1425 (tamibarotene), azacitidine,
Active, not recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- SY-1425 (tamibarotene)
- +2 more
-
Hartford, Connecticut
- +25 more
May 4, 2022
Acute Myeloid Leukemia Trial in Canada, Puerto Rico, United States (procedure, drug, behavioral)
Recruiting
- Acute Myeloid Leukemia
- Allogeneic Hematopoietic Stem Cell Transplantation
- +13 more
-
Birmingham, Alabama
- +187 more
Apr 28, 2022
Acute Myeloid Leukemia Trial in Worldwide (Alvocidib, Cytarabine, Mitoxantrone)
Acute Myeloid Leukemia Trial in Worldwide (Uproleselan, Placebo)
Active, not recruiting
- Acute Myeloid Leukemia
- Uproleselan
- Placebo
-
La Jolla, California
- +69 more
Apr 5, 2022
Acute Myeloid Leukemia, Blasts 20-30 Percent of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia Trial in Baltimore,
Active, not recruiting
- Acute Myeloid Leukemia
- +6 more
- Azacitidine
- +2 more
-
Baltimore, Maryland
- +2 more
Feb 25, 2022
Acute Myeloid Leukemia Trial in Worldwide (Pracinostat, Placebos, Azacitidine)
Acute Myeloid Leukemia, MDS Trial in United States (CG-806)
Recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
-
Duarte, California
- +9 more
Mar 4, 2022
Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute Trial in Canada, United States (Iomab-B, Conventional
Active, not recruiting
- Acute Myeloid Leukemia
- +8 more
- Iomab-B
- +2 more
-
Gilbert, Arizona
- +23 more
Feb 22, 2022